BONE BIOLOGICS CORPORATION (BBLG) Net income 2016–2025
BONE BIOLOGICS CORPORATION (BBLG) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$3.1MFY2025 · since FY2016: -$25.9M → -$3.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.1M | +24.4% |
| FY2024 | -$4.1M | +54.0% |
| FY2023 | -$8.9M | -502.8% |
| FY2022 | -$1.5M | +7.8% |
| FY2021 | -$1.6M | +11.7% |
| FY2020 | -$1.8M | +46.7% |
| FY2019 | -$3.4M | +22.7% |
| FY2018 | -$4.4M | +37.2% |
| FY2017 | -$7.1M | +72.8% |
| FY2016 | -$25.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice